As of April 19, 2025, ADC Therapeutics (ADCT) has a market cap of $0.12 billion USD. According to our data, ADC Therapeutics is ranked No.7433 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.12 B |
-37.69%
|
Dec 31, 2024 | $0.19 B |
19.88%
|
Dec 29, 2023 | $0.16 B |
-56.77%
|
Dec 30, 2022 | $0.37 B |
-80.99%
|
Dec 31, 2021 | $1.95 B |
-36.89%
|
Dec 31, 2020 | $3.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Mersana Therapeutics
MRSN
|
$44.21 M |
-0.037 M
|
![]() USA
|
![]() BioAtla
BCAB
|
$18.91 M |
-0.012 M
|
![]() USA
|
![]() Sutro Biopharma
STRO
|
$43.95 M |
0.385 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
![]() Canada
|
![]() Genmab
GMAB
|
$12.54 B |
-0.000 M
|
![]() Denmark
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Pieris Pharmaceuticals
PIRS
|
$17.96 M |
0.000 M
|
![]() USA
|
![]() CytomX Therapeutics
CTMX
|
$52.55 M |
0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
-0.670 M
|
![]() USA
|
![]() ADC Therapeutics
ADCT
|
$0.12 B |
-0.000 M
|
![]() Switzerland
|
Market Cap | = | ADCT Stock Price | * | ADCT Shares Outstanding |
= | $1.21 | * | 99.08 M | |
= | $0.12 B |